期刊
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
卷 59, 期 -, 页码 S71-S80出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/10408398.2018.1509201
关键词
All-trans retinoic acid; acute promyelocytic leukemia; retinoic acid receptors; chemotherapy; epigenetic modifiers; differentiation
资金
- Natural Science Foundation of Shanghai [17ZR1417100]
All-trans retinoic acid (ATRA), an active metabolite of vitamin A, plays important roles in cell proliferation, cell differentiation, apoptosis, and embryonic development. The effects of ATRA are mediated by nuclear retinoid receptors as well as non-genomic signal pathway, such as MAPK and PKA. The great success of differentiation therapy with ATRA in acute promyelocytic leukemia (APL) not only improved the prognosis of APL but also spurred the studies of ATRA in the treatment of other tumors. Since the genetic and physiopathological simplicity of APL is not common in human malignancies, the combination of ATRA with other agents (chemotherapy, epigenetic modifiers, and arsenic trioxide, etc) had been extensively investigated in a variety of tumors. In this review, we will discuss in details about ATRA and its role in cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据